Clinical trial

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

NCT00329095 · Robin, Alan L., M.D., Other · Completed

Key facts

NCT number NCT00329095
Title An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
Official title An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures
Lead sponsor Robin, Alan L., M.D., Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Glaucoma, Ocular Hypertension
Intervention type Drug
Interventions travoprost, latanoprost, or bimatoprost, Additional ocular hypotensive medication
Enrollment 60
Start date Dec 1, 2005
Completion Apr 1, 2006
First posted May 24, 2006
Last update posted May 24, 2006

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies